Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ruboxistaurin (LY333531) is a selective, orally active PKC beta inhibitor with a Ki value of 2 nM. Ruboxistaurin competitively inhibits PKC beta I (IC50: 4.7 nM) in an ATP-dependent manner. Ruboxistaurin is able to act on PKC beta II (IC50: 5.9 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $691 | 1-2 weeks | |
50 mg | $898 | 1-2 weeks |
Description | Ruboxistaurin (LY333531) is a selective, orally active PKC beta inhibitor with a Ki value of 2 nM. Ruboxistaurin competitively inhibits PKC beta I (IC50: 4.7 nM) in an ATP-dependent manner. Ruboxistaurin is able to act on PKC beta II (IC50: 5.9 nM). |
Targets&IC50 | PKCδ:250 nM, PKCη:52 nM, PKCε:600 nM, PKCα:360 nM, PKCβII:5.9 nM, PKCγ:300 nM, PKCβI:4.7 nM |
Molecular Weight | 468.55 |
Formula | C28H28N4O3 |
Cas No. | 169939-94-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.